Biotech · Private company
Gradalis, Inc.
Track this companyFree. Adds Gradalis, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials101 recruiting or active
Pipeline programs17From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline17
- IrinotecanPhase 3 · Ewing SarcomaClinicalTrials.gov · fetched Nov 12, 2026
- TemozolomidePhase 3 · Ewing SarcomaClinicalTrials.gov · fetched Nov 12, 2026
- VigilPhase 3 · Ewing SarcomaClinicalTrials.gov · fetched Nov 12, 2026
- AtezolizumabPhase 2 · Advanced Gynecological CancersClinicalTrials.gov · fetched Nov 12, 2026
- BevacizumabPhase 2 · Stage III Ovarian CancerClinicalTrials.gov · fetched Nov 12, 2026
- DocetaxelPhase 2 · Ewing's SarcomaClinicalTrials.gov · fetched Nov 12, 2026
- GemcitabinePhase 2 · Ewing's SarcomaClinicalTrials.gov · fetched Nov 12, 2026
- IrinotecanPhase 2 · Ewing's SarcomaClinicalTrials.gov · fetched Nov 12, 2026
- TemozolomidePhase 2 · Ewing's SarcomaClinicalTrials.gov · fetched Nov 12, 2026
- VigilPhase 2 · Advanced Gynecological CancersClinicalTrials.gov · fetched Nov 12, 2026
- VigilPhase 2 · Ovarian CancerClinicalTrials.gov · fetched Nov 12, 2026
- VigilPhase 2 · Ewing's SarcomaClinicalTrials.gov · fetched Nov 12, 2026
- Vigil™ VaccinePhase 2 · Stage III Ovarian CancerClinicalTrials.gov · fetched Nov 12, 2026
- Vigil™ VaccinePhase 2 · Colon CancerClinicalTrials.gov · fetched Nov 12, 2026
- pbi-shRNA™ EWS/FLI1 Type 1 LipoplexPhase 1 · Ewing's SarcomaClinicalTrials.gov · fetched Nov 12, 2026
- Vigil™Phase 1 · Ewings SarcomaClinicalTrials.gov · fetched Nov 12, 2026
- VigilSolid TumorClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials10
- A Trial For Participants With Ewing's Sarcoma Treated With Vigil in Combination With Irinotecan and TemozolomidePHASE3 · TERMINATED · started Aug 21, 2018ClinicalTrials.gov NCT03495921 · fetched Nov 12, 2026
- A Trial of Atezolizumab and Vigil in Patients With Advanced Gynecological CancersPHASE2 · COMPLETED · started May 31, 2017ClinicalTrials.gov NCT03073525 · fetched Nov 12, 2026
- Pbi-shRNA™ EWS/FLI1 Type 1 LPX in Subjects With Advanced Ewing's SarcomaPHASE1 · COMPLETED · started Oct 1, 2016ClinicalTrials.gov NCT02736565 · fetched Nov 12, 2026
- A Two-part Phase IIb Trial of Vigil (Bi-shRNAfurin and GMCSF Augmented Autologous Tumor Cell Immunotherapy) in Ewing's SarcomaPHASE2 · COMPLETED · started Feb 10, 2016ClinicalTrials.gov NCT02511132 · fetched Nov 12, 2026
- A Trial of Vigil for Participants With Ovarian CancerPHASE2 · ACTIVE_NOT_RECRUITING · started Feb 1, 2015ClinicalTrials.gov NCT02346747 · fetched Nov 12, 2026
- Randomized Phase II Adjuvant Chemotherapy ± FANG™ in Colorectal Carcinoma With Liver MetastasesPHASE2 · TERMINATED · started Mar 1, 2012ClinicalTrials.gov NCT01505166 · fetched Nov 12, 2026
- Salvage Ovarian FANG™ Vaccine + BevacizumabPHASE2 · COMPLETED · started Mar 1, 2012ClinicalTrials.gov NCT01551745 · fetched Nov 12, 2026
- A Trial of FANG™ Vaccine for Participants With Ovarian CancerPHASE2 · COMPLETED · started Mar 8, 2011ClinicalTrials.gov NCT01309230 · fetched Nov 12, 2026
- Trial of Bi-shRNA-furin and GMCSF Augmented Autologous Tumor Cell Vaccine for Advanced CancerPHASE1 · COMPLETED · started Dec 1, 2009ClinicalTrials.gov NCT01061840 · fetched Nov 12, 2026
- Expanded Access of Vigil in Solid TumorsTEMPORARILY_NOT_AVAILABLEClinicalTrials.gov NCT03842865 · fetched Nov 12, 2026